Thavakumar Subramaniam
Papers
1
Total Citations
10
H-Index
1
About
Dr. Thavakumar Subramaniam is a leading surgical oncologist whose research focuses on optimizing treatment paradigms for human papillomavirus (HPV)-related oropharyngeal squamous cell carcinoma (OPSCC). His major contributions center on integrating neoadjuvant chemotherapy with transoral robotic surgery (TORS) to address the critical challenge of distant metastasis—the primary cause of death in these patients—while minimizing treatment-related toxicities. His landmark 2024 study on this combined approach has already garnered 10 citations, reflecting its immediate impact on clinical practice. Dr. Subramaniam’s work is notable for its patient-centered design, aiming to reduce the long-term side effects of traditional therapies without compromising oncologic outcomes. By pioneering less invasive, targeted strategies, he is reshaping the standard of care for HPV-related OPSCC, offering hope for improved survival and quality of life. His research continues to influence head and neck oncology, making him a key figure in the field.
Research Focus
Key Achievements
Top Papers
- 1